Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

PTSD linked to increased risk of hypothyroidism among women

19 Nov 2019

Women with post-traumatic stress disorder (PTSD) are at increased risk of developing thyroid dysfunction, a study reports.

The study included 45,992 women from the ongoing Nurses’ Health Study II. Thirty percent of these women reported having no history of traumatic events, 50 percent reported being exposed to trauma with no PTSD symptoms, and 4 percent reported the highest number (6–7) of PTSD symptoms.

Relative to those who did not experience any trauma, women with the highest number of PTSD symptoms were more likely to have the highest somatotype at age 5 years, have a higher body mass index, smoke frequently, use oral contraceptives, be menopausal, and use ibuprofen medication and antidepressants.

Over a follow-up of 24 years, hypothyroidism occurred in 7,993 women and Graves’ hyperthyroidism in 847. Hypothyroidism showed a dose-response association with PTSD symptoms, with the incidence higher in the group of women presenting with a greater number of PTSD symptoms. This was not observed for Grave’s hyperthyroidism.

In multivariable Cox models, the hazard ratios for hypothyroidism were 1.08 (95 percent confidence interval [CI], 1.02–1.15) in women with trauma with no PTSD symptoms; 1.12 (95 percent CI, 1.04–1.21) in those with 1–3 PTSD symptoms; 1.23 (95 percent CI, 1.13–1.34) in those with 4–5 symptoms; and 1.26 (95 percent CI, 1.14–1.40) with 6–7 symptoms (p-trend<0.001).

The association persisted in sensitivity analyses restricted to outcomes with onset after 2008 when PTSD was assessed.

The present data underscore the importance of awareness for thyroid dysfunction in women with PTSD, according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.